37 results on '"Bisping, Guido"'
Search Results
2. Laparoscopic splenectomy for medically refractory immune thrombocytopenia (ITP): A retrospective cohort study on longtime response predicting factors based on consensus criteria
3. Diagnosis, prevention, and management of bleeding episodes in Philadelphia-negative myeloproliferative neoplasms: recommendations by the Hemostasis Working Party of the German Society of Hematology and Medical Oncology (DGHO) and the Society of Thrombosis and Hemostasis Research (GTH)
4. Primary Thromboprophylaxis in Patients with Malignancies: Daily Practice Recommendations by the Hemostasis Working Party of the German Society of Hematology and Medical Oncology (DGHO), the Society of Thrombosis and Hemostasis Research (GTH), and the Austrian Society of Hematology and Oncology (ÖGHO)
5. Targeting receptor kinases by a novel indolinone derivative in multiple myeloma: abrogation of stroma-derived interleukin-6 secretion and induction of apoptosis in cytogenetically defined subgroups
6. Proteasome inhibition in multiple myeloma
7. Minireview: Malassezia infections in immunocompromised patients
8. Combination of romiplostim and rituximab: effective therapy of severe immune thrombocytopenia
9. Bortezomib in combination with dexamethasone for relapsed multiple myeloma
10. Bortezomib in combination with intermediate-dose dexamethasone and continuous low-dose oral cyclophosphamide for relapsed multiple myeloma
11. Graft-versus-host disease after allogeneic hematopoietic stem cell transplantation induces a CD8+ T cell-mediated graft-versus-tumor effect that is independent of the recognition of alloantigenic tumor targets
12. Hyperfractionated cyclophosphamide in combination with pulsed dexamethasone and thalidomide (HyperCDT) in primary refractory or relapsed multiple myeloma
13. Paracrine interactions of basic fibroblast growth factor and interleukin-6 in multiple myeloma
14. Neuroendokrine Neoplasien im deutschen NET-Register
15. Neuroendokrine Neoplasien im deutschen NET-Register
16. Cancer Screening in Patients with Idiopathic Venous Thromboembolism - a Position Paper of the German Society of Hematology and Oncology Working Group on Hemostasis
17. Untersuchungen zur Proteinexpression verschiedener Proteinkinase C-Subtypen bei frühen neoplastischen Veränderungen humaner Kolonzellen
18. Untersuchungen zur Proteinexpression verschiedener Proteinkinase C -Subtypen bei frühen neoplastischen Veränderungen humaner Kolonzellen
19. Anti-Myeloma Activity of LDC-000067, a Novel Selective Inhibitor of Cyclin Dependent Kinase 9: A Targeted Approach
20. Immunological Intervention Triggered by Decreasing CD34 + Lineage-Specific Donor Cell Chimerism to Prevent Relapse of Acute Myeloid Leukemia (AML) or Myelodysplastic Syndrome (MDS) After Allogeneic Hematopoietic Stem Cell Transplantation (HSCT).
21. Activated Human γδ T Cells as Stimulators of Specific CD8+ T-cell Responses to Subdominant Epstein Barr Virus Epitopes
22. Bortezomib, Dexamethasone, and Fibroblast Growth Factor Receptor 3–Specific Tyrosine Kinase Inhibitor in t(4;14) Myeloma
23. Paracrine interactions of vascular endothelial growth factor and platelet-derived growth factor in endothelial and lung cancer cells
24. Differential Requirement for a Cellular Type-1 Immune Response in Tumor-Associated Versus Alloantigen-Targeted GvT Effects
25. Growth inhibition and induction of apoptosis in acute myeloid leukemia cells by new indolinone derivatives targeting fibroblast growth factor, platelet-derived growth factor, and vascular endothelial growth factor receptors
26. Enhanced Anti-Myeloma Activity by Combination of Receptor Tyrosine Kinase (RTK) Inhibition, Proteasome Inhibition, and Dexamethasone: Therapeutic Implications for t(4;14) and t(14;16) Multiple Myeloma (MM) Subgroups.
27. Bortezomib in Combination with High-Dose Dexamethasone and Continuous Low-Dose Oral Cyclophosphamide for Relapsed Multiple Myeloma.
28. Bortezomib in Combination with Dexamethasone for Relapsed Multiple Myeloma.
29. Differential diagnosis of “dysphagia” in an elderly woman
30. Cytotoxic lymphocytes of patients with inflammatory bowel disease reveal increased induction capacity of intracellular IFN-Г co-cultured with intestinal epithelial cells — a MHC-class I restricted pathway?
31. Anti-proliferative activity of protein kinase C in apical compartments of human colonic crypts: Evidence for a less activated protein kinase C in small adenomas
32. Do human myeloma cells directly produce basic FGF?
33. Characterization of Hematopoietic Progenitor Kinase 1 (HPK1) in Multiple Myeloma: a Player in Pathogenesis?,
34. Graft-versus-host disease after allogeneic hematopoietic stem cell transplantation induces a CD8+T cell-mediated graft-versus-tumor effect that is independent of the recognition of alloantigenic tumor targets
35. Immunological Intervention Triggered by Decreasing CD34 +Lineage-Specific Donor Cell Chimerism to Prevent Relapse of Acute Myeloid Leukemia (AML) or Myelodysplastic Syndrome (MDS) After Allogeneic Hematopoietic Stem Cell Transplantation (HSCT).
36. An open-label dose-escalation study of BIBF 1120 in patients with relapsed or refractory multiple myeloma.
37. Activated human gammadelta T cells as stimulators of specific CD8+ T-cell responses to subdominant Epstein Barr virus epitopes: potential for immunotherapy of cancer.
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.